Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...

The Supraventricular Tachycardia market benefits from aging populations, technological advances like catheter ablation, rising cardiovascular awareness, and wearable diagnostics. Growth is supported ...

Adagio Medical Holdings, Inc (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication ...

Field Medical announced the presentation of clinical data from the first-in-human study of its FieldForce pulsed field ...

PARIS — Catheter ablation has been placed front and center in the latest guidelines for the management of supraventricular tachycardia (SVT) from the European Society of Cardiology (ESC). The ...

Untreated or unmanaged, SVT can lead to other possibly fatal heart abnormalities. Patients are advised to practice a cardiac-friendly diet and lifestyle (low sodium, little to no caffeine or alcohol, ...

Deltona, Fla.-based Advanced Heart and Vascular Surgery Center, an affiliate of Cardiovascular Centers of America, has become the first ASC in Florida to launch a complete cardiac ablation service ...

Initial strategy of catheter ablation leads to lower risk for composite primary end point versus antiarrhythmic drug therapy. (HealthDay News) — An initial strategy of catheter ablation leads to a ...

Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...